| Literature DB >> 26856980 |
Atif Ali Hashmi1, ZubaidaFida Hussain2, Muhammad Muzzammil Edhi3, Shazia Mumtaz4, Naveen Faridi5, Mehmood Khan6.
Abstract
BACKGROUND: Idiopathic nephrotic syndrome encompasses diverse histogenetic patterns and depicts socioeconomic and demographic differences attributable to genetic profile, environmental factors and prevalence of infectious diseases. A lack of renal registry in our country necessitates a need to document changing histologic patterns of nephrotic syndrome as noted in different parts of the world.Entities:
Mesh:
Year: 2016 PMID: 26856980 PMCID: PMC4745154 DOI: 10.1186/s13104-016-1876-y
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Gender distribution and mean age of primary and secondary glomerulonephritis
| Total | Male | Female | Age | |||
|---|---|---|---|---|---|---|
| n | % | n | % | Mean | ||
| Primary glomerulonephritis | ||||||
| Minimal change disease | 12 | 7 | 58.3 | 5 | 41.7 | 30 |
| Focal segmental glomerulonephritis | 20 | 10 | 50.0 | 10 | 50.0 | 32 |
| Membranous glomerulonephritis | 33 | 17 | 51.5 | 16 | 48.5 | 38 |
| Membranoproliferative glomerulonephritis | 15 | 7 | 46.7 | 8 | 53.3 | 37 |
| Acute proliferative GN | 7 | 2 | 28.6 | 5 | 71.4 | 35 |
| IgA nephropathy | 9 | 4 | 44.4 | 5 | 55.6 | 27 |
| Cresentic GN, immune complex type | 2 | 2 | 100.0 | 0 | 0 | 44 |
| Secondary glomerulonephritis | ||||||
| Lupus nephritis | 20 | 6 | 30.0 | 14 | 70.0 | 25 |
| Cresentic GN, pauciimmune type/Wegener disease | 3 | 2 | 66.7 | 1 | 33.3 | 49 |
| Diabetic glomerulosclerosis | 7 | 4 | 57.1 | 3 | 42.9 | 48 |
| Amyloidosis | 7 | 1 | 14.3 | 6 | 85.7 | 37 |
| Hypertensive nephropathy | 2 | 1 | 50.0 | 1 | 50.0 | 53 |
| Chronic sclerosing glomerulonephritis (ESRD) | 3 | 2 | 66.7 | 1 | 33.3 | 52 |
Age distribution of primary glomerulonephritis
| Less than 18 years | 19–30 years | 31–50 years | More than 50 years | |||||
|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | |
| Minimal change disease | 5 | 41.7 | 2 | 16.7 | 3 | 25.0 | 2 | 16.7 |
| Focal segmental glomerulonephritis | 3 | 15.0 | 9 | 45.0 | 5 | 25.0 | 3 | 15.0 |
| Membranous glomerulonephritis | 3 | 9.1 | 10 | 30.3 | 12 | 36.4 | 8 | 24.2 |
| Membranoproliferative glomerulonephritis | 2 | 13.3 | 4 | 26.7 | 5 | 33.3 | 4 | 26.7 |
| Acute proliferative GN | 2 | 28.6 | 1 | 14.3 | 2 | 28.6 | 2 | 28.6 |
| IgA nephropathy | 2 | 22.2 | 3 | 33.3 | 4 | 44.4 | 0 | 0 |
| Cresentic GN, immune complex type | 0 | 0 | 1 | 50.0 | 0 | 0 | 1 | 50.0 |
Clinical presentation of different types of primary glomerulonephritis
| Nephrotic syndrome | Nephritic syndrome | |||
|---|---|---|---|---|
| N | % | N | % | |
| Primary glomerulonephritis | ||||
| Minimal change disease | 12 | 14.2 | 0 | 0 |
| Focal segmental glomerulonephritis | 18 | 21.4 | 2 | 14.2 |
| Membranous glomerulonephritis | 32 | 38.0 | 1 | 7.1 |
| Membranoproliferative glomerulonephritis | 14 | 13.0 | 1 | 7.1 |
| Acute proliferative GN | 1 | 1.1 | 6 | 42.8 |
| IgA nephropathy | 5 | 5.9 | 4 | 28.5 |
| Cresentic GN, immune complex type | 2 | 2.3 | 0 | 0 |
| Total | 84 | 14 | ||
Immunoflourescence patterns of primary and secondary glomerulonephritis
| Immunoglobulins | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| IgG | IgM | IgA | C3c | C1q | ||||||
| N | % | N | % | N | % | N | % | N | % | |
| Primary glomerulonephritis | ||||||||||
| Minimal change disease | 2 | 16.6 | 7 | 58.3 | 4 | 33.3 | 5 | 41.6 | 2 | 16.6 |
| Focal segmental glomerulonephritis | 2 | 10.0 | 17 | 85.0 | 5 | 25.0 | 12 | 60.0 | 7 | 35.0 |
| Membranous glomerulonephritis | 28 | 84.8 | 27 | 81.8 | 18 | 54.5 | 29 | 87.8 | 23 | 69.6 |
| Membranoproliferative glomerulonephritis | 10 | 66.7 | 13 | 86.7 | 13 | 86.7 | 15 | 100 | 10 | 66.7 |
| Acute proliferative GN | 6 | 85.7 | 4 | 57.1 | 4 | 57.1 | 7 | 100 | 4 | 57.1 |
| IgA nephropathy | 1 | 11.1 | 9 | 100 | 9 | 100 | 8 | 88.9 | 4 | 44.4 |
| Cresentic GN, immune complex type | 1 | 50.0 | 2 | 100 | 2 | 100 | 2 | 100 | 2 | 100 |
| Secondary glomerulonephritis | ||||||||||
| Lupus nephritis | 20 | 100 | 20 | 100 | 19 | 95.0 | 20 | 100 | 20 | 100 |
| Cresentic GN, pauciimmune type/Wegener disease | 1 | 33.3 | 2 | 66.7 | 0 | 0 | 2 | 66.7 | 1 | 33.3 |
| Diabetic glomerulosclerosis | 4 | 57.1 | 6 | 85.7 | 4 | 57.1 | 4 | 57.1 | 1 | 14.2 |
| Amyloidosis | 4 | 57.1 | 3 | 42.8 | 2 | 28.6 | 4 | 57.1 | 2 | 28.6 |
| Hypertensive nephropathy | 2 | 100 | 2 | 100 | 1 | 50.0 | 2 | 100 | 1 | 50.0 |
| Chronic sclerosing glomerulonephritis (ESRD) | 0 | 0 | 3 | 100 | 0 | 0 | 3 | 100 | 1 | 33.3 |